Trials / Completed
CompletedNCT02016482
A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis
A Phase 3, Multicenter, Double-Blind, Randomized, Parallel-Arm, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Adalimumab for Treatment of Nail Psoriasis in Patients With Chronic Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 217 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study is being conducted to assess the safety and efficacy of adalimumab in participants with nail psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Adalimumab | |
| OTHER | Placebo |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-10-01
- Completion
- 2016-04-01
- First posted
- 2013-12-20
- Last updated
- 2017-05-30
- Results posted
- 2017-02-13
Source: ClinicalTrials.gov record NCT02016482. Inclusion in this directory is not an endorsement.